FHIR IG Statistics: ValueSet/2.16.840.1.113762.1.4.1078.1026
| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | 2.16.840.1.113762.1.4.1078.1026 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1078.1026/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1026 |
| Version | 20250403 |
| Status | active |
| Date | 2025-04-03T01:09:26-04:00 |
| Name | ACEInhibitorAllergyNDFRT |
| Title | ACE inhibitor Allergy NDFRT |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: NDFRT codes for tge drug class ACE inhibitors),(Data Element Scope: NDFRT codes representing the ACE inhibitor class),(Inclusion Criteria: Codes which are (1) Chemical/Ingredient (2) EPC, or (3) MoA),(Exclusion Criteria: N/A) |
Resources that use this resource
Resources that this resource uses
| CodeSystem |
| ndfrt | National Drug File Reference Terminology (NDF-RT) |
Narrative
No narrative content found in resource
Source
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113762.1.4.1078.1026",
"meta": {
"versionId": "19",
"lastUpdated": "2025-04-03T01:09:26.000-04:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "Optum Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2025-04-03"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2025-04-03"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1026",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113762.1.4.1078.1026"
}
],
"version": "20250403",
"name": "ACEInhibitorAllergyNDFRT",
"title": "ACE inhibitor Allergy NDFRT",
"status": "active",
"date": "2025-04-03T01:09:26-04:00",
"publisher": "Optum Steward",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: NDFRT codes for tge drug class ACE inhibitors),(Data Element Scope: NDFRT codes representing the ACE inhibitor class),(Inclusion Criteria: Codes which are (1) Chemical/Ingredient (2) EPC, or (3) MoA),(Exclusion Criteria: N/A)",
"compose": {
"include": [
{
"system": "http://hl7.org/fhir/ndfrt",
"concept": [
{
"code": "N0000000181",
"display": "Angiotensin-converting Enzyme Inhibitors [MoA]"
},
{
"code": "N0000175562",
"display": "Angiotensin Converting Enzyme Inhibitor [EPC]"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:43905c6a-5dc0-42b4-8a90-e6d3d0ae78aa",
"timestamp": "2025-05-23T17:44:40-04:00",
"total": 2,
"contains": [
{
"system": "http://hl7.org/fhir/ndfrt",
"version": "20180301",
"code": "N0000000181",
"display": "Angiotensin-converting Enzyme Inhibitors [MoA]"
},
{
"system": "http://hl7.org/fhir/ndfrt",
"version": "20180301",
"code": "N0000175562",
"display": "Angiotensin Converting Enzyme Inhibitor [EPC]"
}
]
}
}
FHIR